Mutations within a conserved protein kinase A recognition sequence confer temperature-sensitive and partially defective activities onto mouse c-Rel

Biochemical and Biophysical Research Communications

Volumn 307, Issue 1, 2003, Pages 92-99

  Gapuzan, Maria Emily R ^a   Pitoc, George A ^a,b   Gilmore, Thomas D ^a  

^a Boston University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

c Rel; NF B; Rel; RelA; Site directed mutagenesis; Temperature sensitive mutant; Transcription factor

Indexed keywords

AMINO ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; DROSOPHILA PROTEIN; MUTANT PROTEIN; PROTEIN P50; TRANSCRIPTION FACTOR REL;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DROSOPHILA; GENE MUTATION; IN VITRO STUDY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; TRANSCRIPTION INITIATION;

EID: 0037711555     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01123-9     Document Type: Article

References (26)

1. Gilmore T.D. The Rel/NF-κB signal transduction pathway: introduction. Oncogene. 18:1999;6842-6844.
2. Pahl H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 18:1999;6853-6866.
3. Isoda K., Roth S., Nüsslein-Volhard C. The functional domains of the Drosophila morphogen dorsal: evidence from the analysis of mutants. Genes Dev. 6:1992;619-630.
4. White D.W., Gilmore T.D. Temperature-sensitive transforming mutants of the v-rel oncogene. J. Virol. 67:1993;6876-6881.
5. Kumar S., Rabson A.B., Gélinas C. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12:1992;3094-3106.
6. Huang D.B., Chen Y.Q., Ruetsche M., Phelps C.B., Ghosh G. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure. 9:2001;669-678.
7. Mosialos G., Gilmore T.D. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene. 8:1993;721-730.
8. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:1985;488-492.
9. White D.W., Roy A., Gilmore T.D. The v-Rel oncoprotein blocks apoptosis and proteolysis of IκB-α in transformed chicken spleen cells. Oncogene. 10:1995;857-868.
10. Capobianco A.J., Gilmore T.D. Repression of the chicken c-rel promoter by v-Rel in chicken embryo fibroblasts is not mediated through a consensus NF-κB binding site. Oncogene. 6:1991;2203-2210.
11. Kalaitzidis D., Davis R.E., Rosenwald A., Staudt L.M., Gilmore T.D. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway. Oncogene. 21:2002;8759-8768.
12. Thanos D., Maniatis T. Identification of the rel family members required for virus induction of the human interferon gene. Mol. Cell. Biol. 15:1995;152-164.
13. White D.W., Gilmore T.D. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκBα in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene. 13:1996;891-899.
14. You M., Ku P., Hrdlicková R., Bose H.R. Jr. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol. 17:1997;7328-7341.
15. Capobianco A.J., Chang D., Mosialos G., Gilmore T.D. p105, the NF-κB p50 precursor, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J. Virol. 66:1992;3758-3767.
16. White D.W., Pitoc G.A., Gilmore T.D. Interaction of the v-Rel oncoprotein with NF-κB and IκB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-κB p52 are functional in vitro and in vivo. Mol. Cell. Biol. 16:1996;1169-1178.
17. Day Y.S.N., Bacon S.L., Hughes-Thomas Z., Blackbrun J.M., Sutherland J.D. Mutational analysis of the kinetics and thermodynamics of transcription factor NF-κB homodimerisation. ChemBioChem. 3:2000;192-1199.
18. Malay A.D., Procious S.L., Tolan D.R. The temperature dependence of activity and structure for the most prevalent mutant aldolase B associated with hereditary fructose intolerance. Arch. Biochem. Biophys. 2002;295-304.
19. Ryseck R.-P., Novotny J., Bravo R. Characterization of elements determining the dimerization properties of RelB and p50. Mol. Cell. Biol. 15:1995;3100-3109.
20. Ganchi P.A., Sun S.-C., Greene W.C., Ballard D.W. A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol. Cell. Biol. 13:1993;7826-7835.
21. Gapuzan M.-E.R., Yufit P.V., Gilmore T.D. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype. Oncogene. 21:2002;2484-2492.
22. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:1998;661-671.
23. Okazaki T., Sakon S., Sasazuki T., Sakurai H., Doi T., Yagita H., Okumura K., Nakano H. Phosphorylation of serine 276 is essential of p65 NF-κB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300:2003;807-812.
24. Vermeulen L., De Widle G., Damme P.V., Vanden Berghe W., Haegeman G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22:2003;1313-1324.
25. Menetski J.P. The structure of the nuclear factor-κB protein-DNA complex varies with DNA-binding site sequence. J. Biol. Chem. 275:2000;7619-7625.
26. Chen Y.-Q., Ghosh S., Ghosh G. A novel DNA recognition mode by the NF-κB p65 homodimer. Nat. Struct. Biol. 5:1998;67-73.